PrEP Truvada Oral denied due to quantity / dose limits by Cigna?

Cigna's specific coverage criteria for prep truvada oral are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Denied PrEP (Truvada) for Quantity Limits

A quantity-limits denial means Cigna's pharmacy benefit manager approved some supply of oral Truvada but capped the quantity below what your prescriber ordered. For HIV pre-exposure prophylaxis (PrEP), which requires consistent daily adherence to be effective, a quantity limit that results in gaps in supply can directly undermine the clinical purpose of the medication. These denials are frequently overturned when the prescriber documents the clinical necessity of the prescribed supply quantity.

## Why This Denial Is Appealable

Cigna's quantity-limit policies are subject to a medical-exception or quantity-limit exception process. If your prescriber can document that the approved quantity is insufficient for continuous, uninterrupted PrEP therapy — including the specific reason (e.g., dispensing interval, travel, adherence support) — an exception must be considered. A quantity limit that effectively prevents an approved drug from being used as prescribed is also an arguable access barrier under the ACA's preventive-services framework for non-grandfathered plans.

## Federal Appeal Framework

• Quantity-limit exception request: This is the first and typically fastest step. Your prescriber submits a written request documenting why the prescribed quantity is medically necessary. This is separate from but related to the formal appeal.
• Internal appeal (ACA §2719 / ERISA §503): If the exception is denied, you have the right to a full-and-fair internal review. The denial notice states the deadline — preserve it.
• External review: If the internal appeal fails, you may request independent IRO review at no cost, typically within four months of the final denial. Expedited review is available when delay seriously jeopardizes your health.

## Concrete Appeal Process and Timeline

1. Identify the specific quantity approved versus the quantity prescribed. 2. Ask your prescriber to document in the chart and in a letter why the prescribed quantity (and dispensing interval) is medically necessary for uninterrupted PrEP. 3. Submit a quantity-limit exception request with that documentation. 4. If denied, escalate to a formal internal appeal. 5. If internal appeal fails, file for external IRO review within the stated window.

## Documentation to Gather

• Prescription and dispensing records: Documentation of what was prescribed versus what was approved.
• Prescriber letter on supply necessity: An explicit statement from your provider explaining why the prescribed quantity is required for continuous, effective PrEP therapy — addressing the specific gap the quantity limit creates.
• Adherence or continuity documentation: Any clinical notes about adherence counseling or the importance of uninterrupted supply for this patient.
• HIV-negative status: Current labs confirming status and ongoing PrEP candidacy.
• Travel or access factors (if applicable): Documentation of circumstances — such as limited pharmacy access or travel schedule — that make a larger supply medically necessary.

## Criteria-Mapping Structure

Obtain Cigna's quantity-limit exception criteria and complete this table:

| Cigna Quantity-Limit Criterion | Clinical Evidence Meeting It | |---|---| | [Copy exact criterion language from denial or policy] | [Specific note, date, or prescriber statement] |

Addressing each criterion point-by-point — rather than submitting a general appeal letter — significantly increases the likelihood of a favorable outcome for quantity-limit disputes.